- World rank, 2022–2025
- #19,837 of 28,054 · #20,135 all time
- Rank in France
- #916 of 1,422
- Research works
- 378 ▲ 25% vs 2013–17
- Citations
- 8.9k 23.5 per fractional work
- Top-10% rate
- 19.9% record average 16.5%
- Open access
- 34% world 28%
What is Pfizer (France) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #8,506 of 17,978 | 18.8% | 211 | |
| Health SciencesDomain | #11,161 of 20,462 | 17.2% | 239 |
Each strip is that field’s whole ranked pool, with the notch where Pfizer (France) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.2×. Every wedge is a field page.
- Immunology and Microbiology 10.2×
- Medicine 3.3×
- Veterinary 2.6×
- Pharmacology, Toxicology and Pharmaceutics 2.5×
- Economics, Econometrics and Finance 2.5×
- Health Professions 1.8×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Mathematics 0.6×
- Nursing 0.6×
- Neuroscience 0.4×
- Agricultural and Biological Sciences 0.3×
- Decision Sciences 0.3×
- Environmental Science 0.1×
- Psychology 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.1×
- Computer Science 0.1×
- Dentistry 0.1×
- Materials Science 0.0×
- Chemistry 0.0×
- Engineering 0.0×
Who are the top researchers at Pfizer (France)?
Ranked on the composite score, M. Kessouri and S. Fiévez lead among researchers whose main affiliation is Pfizer (France).
- 1 M. Kessouri France · #1,594,516 worldwide 0 citations · 15 works
- 2 S. Fiévez France · #1,624,062 worldwide 1 citations · 17 works
Which keywords describe research at Pfizer (France)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Public Health, Vaccine Development, Pathogenesis, Disease Burden, Clinical Practice Guidelines, Human Metapneumovirus and Respiratory Syncytial Virus.
- Hair Follicle
- Autoantibodies
- Drug Resistance
- Immunity
- Regeneration
- Clinical Management
- Inequalities
- Healthcare Quality Indicators
- Primary Care
- Tick-Borne Diseases
- Immune Response
- Host-Pathogen Interactions
- Pathogen Transmission
- Vaccination
- Community-Acquired Pneumonia
- Inflammation
- Respiratory Syncytial Virus
- Disease Burden
- Pathogenesis
- Public Health
- Epidemiology
- Vaccine Development
- Clinical Practice Guidelines
- Human Metapneumovirus
- Antimicrobial Resistance
- Treatment
- Pneumococcal Conjugate Vaccine
- Diagnosis
- Vaccine
- Quality of Life
- Lyme Disease
- Antibiotic Resistance
- Healthcare Policy
- Social Determinants of Health
- Universal Health Coverage
- Genetic Diversity
- Stem Cells
- Zoonotic Infections
- Wnt Signaling
- Epidermal Niche
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology25▲ 8.2×45 topics
- Public Health8▲ 7.5×12 topics
- Vaccine Development6▲ 31×5 topics
- Pathogenesis6▲ 15×13 topics
- Clinical Practice Guidelines5▲ 12×6 topics
- Disease Burden5▲ 89×2 topics
- Human Metapneumovirus5▲ 136×1 topic
- Respiratory Syncytial Virus5▲ 136×1 topic
- Antimicrobial Resistance5▲ 31×6 topics
- Inflammation4▲ 2.8×23 topics
- Treatment4▲ 4.4×15 topics
- Community-Acquired Pneumonia4▲ 140×1 topic
- Pneumococcal Conjugate Vaccine4▲ 140×1 topic
- Vaccination4▲ 65×2 topics
- Diagnosis3▲ 4.7×13 topics
- Pathogen Transmission3▲ 64×2 topics
- Vaccine3▲ 9.5×7 topics
- Host-Pathogen Interactions3▲ 44×2 topics
- Quality of Life3▲ 2.5×13 topics
- Immune Response3▲ 6.0×9 topics
- Lyme Disease3▲ 146×1 topic
- Tick-Borne Diseases3▲ 146×1 topic
- Antibiotic Resistance2▲ 8.1×5 topics
- Primary Care2▲ 8.4×3 topics
- Healthcare Policy2▲ 32×3 topics
- Healthcare Quality Indicators2▲ 49×2 topics
- Social Determinants of Health2▲ 13×2 topics
- Inequalities2▲ 79×1 topic
- Universal Health Coverage2▲ 79×1 topic
- Clinical Management2▲ 14×6 topics
- Genetic Diversity2▲ 5.6×2 topics
- Regeneration2▲ 12×2 topics
- Stem Cells2▲ 9.9×5 topics
- Immunity2▲ 5.8×5 topics
- Zoonotic Infections2▲ 41×2 topics
- Drug Resistance2▲ 7.6×3 topics
- Wnt Signaling2▲ 21×3 topics
- Autoantibodies2▲ 8.7×5 topics
- Epidermal Niche2▲ 114×1 topic
- Hair Follicle2▲ 114×1 topic
Which research topics does Pfizer (France) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Pneumonia and Respiratory Infections, Vector-borne infectious diseases and Healthcare Systems and Practices.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 5 works
- 2 Pneumonia and Respiratory Infections Epidemiology 4 works
- 3 Vector-borne infectious diseases Parasitology 3 works
- 4 Healthcare Systems and Practices General Health Professions 2 works
- 5 Hair Growth and Disorders Urology 2 works
- 6 Bacterial Infections and Vaccines Microbiology 2 works
- 7 Viral Infections and Vectors Infectious Diseases 2 works
- 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 9 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 1 works
- 10 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (France)'s research output changed?
Output in 2018–2022 was 25% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.